3.04  0.02 (0.66%)		06-24 16:00
Open: 3.03 High: 3.11 Volume: 2,157,155		Pre. Close: 3.02 Low: 2.97 Market Cap: 344(M)

Short term
Mid term
Targets	6-month :	5	1-year :	6.07
Resists	First :	4.28	Second :	5.19
Pivot price	4.01
Supports	First :	2.79	Second :	2.32
MAs	MA(5) :	3.17	MA(20) :	4.06
	MA(100) :	4.78	MA(250) :	3.15
MACD	MACD :	-0.5	Signal :	-0.3
%K %D	K(14,3) :	8.2	D(3) :	9.3
RSI	RSI(14): 30.7
52-week	High :	6.71	Low :	1.11

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ABSI ] has closed above bottom band by 11.9%. Bollinger Bands are 94.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	3.11 - 3.13	3.13 - 3.14
Low:	2.94 - 2.95	2.95 - 2.97
Close:	3.02 - 3.04	3.04 - 3.06

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Fri, 21 Jun 2024
7 Best Halal Stocks To Buy Now (Debt Free) - Insider Monkey

Mon, 17 Jun 2024
Is Absci (NASDAQ:ABSI) A Risky Investment? - Simply Wall St

Thu, 13 Jun 2024
Absci (NASDAQ:ABSI) Trading Down 6% - MarketBeat

Wed, 12 Jun 2024
Absci to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit - StockTitan

Wed, 12 Jun 2024
Absci to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit - GlobeNewswire

Tue, 28 May 2024
Phoenix venture partners II LP sells $13.64 million in AbSci Corp stock By Investing.com - Investing.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	0 (M)
Shares Float	113 (M)
Held by Insiders	8.406e+007 (%)
Held by Institutions	20.4 (%)
Shares Short	8,630 (K)
Shares Short P.Month	0 (K)

EPS	-7.878e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-2 %
Return on Assets (ttm)	616.7 %
Return on Equity (ttm)	-20.3 %
Qtrly Rev. Growth	5.35e+006 %
Gross Profit (p.s.)	-12.7
Sales Per Share	-19.22
EBITDA (p.s.)	0
Qtrly Earnings Growth	-1.2 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-62 (M)

PE Ratio	-0.01
PEG Ratio	-0.2
Price to Book value	0
Price to Sales	-0.16
Price to Cash Flow	3.29

Dividend	0
Forward Dividend	7.72e+006
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.